INmune Bio Inc (INMB) Stock Price, Quote, News & History

INMBNASDAQ
$1.45
0.1511.54%
At close: Jun 18, 5:00 PM EST
$1.41
-0.0397-2.74%
After Hours: 7:46 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-19.16M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
22.34M
Free Cash Flow (TTM)
-20.20M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
2.13M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$18.70M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.75
Earnings Yield % (TTM)
-126.36%
Earnings Yield % (FWD)
-40.70%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.74

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$21.36M
Debt to Equity
0.08
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.32
Close
$1.45
Volume / Avg.
446.95K / 391.16K
Day Range
$1.32 - $1.45
52 Wk Range
1.09 - 11.64
Market Cap
$37.49M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
15.62%
Days to Cover
14.38

About

Sector
Health Care
Industry
Biotechnology
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy INmune Bio (INMB) stock?

A

You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are INmune Bio (INMB) competitors?

A

There are no as such competitors for INmune Bio.

Q

What is the forecast, or price target, for INmune Bio (INMB) stock?

A

INmune Bio has a consensus price target of $9.93.

Q

What is the current price for INmune Bio (INMB)?

A

The stock price for INmune Bio (NASDAQ: INMB) is $1.4103 last updated June 18, 2026 at 7:46 PM EDT.

Q

Does INmune Bio (INMB) pay a dividend?

A

There are no upcoming dividends for INmune Bio.

Q

When is INmune Bio (NASDAQ:INMB) reporting earnings?

A

INmune Bio does not have any upcoming earnings scheduled.

Q

Is INmune Bio (INMB) going to split?

A

There is no upcoming split for INmune Bio.

Q

What sector and industry does INmune Bio (INMB) operate in?

A

INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.